Risner ME, Saunders AM, Altman JF, Ormandy GC, Craft S, Foley IM, Zvartau-Hind ME, Hosford DA, Roses AD, . Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease. Pharmacogenomics J. 2006 Jul-Aug;6(4):246-54. PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

Therapeutics

  1. Rosiglitazone

News

  1. Madrid: Highs and Lows of The Insulin Connection
  2. Trial Updates: B Vitamin Back in Vogue? Diabetes Drug Less Sweet
  3. Washington: Shaking Up AD Treatment with Ketone Bodies
  4. Chicago: Studies Probe Diminishing Placebo Decline, Part 2
  5. Boston: Drug Development Strategies for Neuro Diseases